InsiderTrades.com logo
Missed Nvidia? Buy Elon Musk’s “Silent Partner”
From Brownstone Research   |   Ad
In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.
So please click here to see the details because a lot of people could get rich.
Corinne Pankovcin net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Corinne Pankovcin Biography and Net Worth

CFO of Aditxt
Served as Chief Financial Officer for several world class organizations including; Business Development Corporation of America (“BDCA”), BlackRock Kelso Capital (NASDAQ BKCC) and AIG Capital Partners. Responsible for executing portfolio investments and managing significant M&A transactions throughout her career.

What is Corinne Pankovcin's net worth?

The estimated net worth of Corinne Pankovcin is at least $13.21 as of May 25th, 2021. Ms. Pankovcin owns 71 shares of Aditxt stock worth more than $13 as of December 22nd. This net worth estimate does not reflect any other investments that Ms. Pankovcin may own. Additionally, Ms. Pankovcin receives a salary of $366,770.00 as CFO at Aditxt. Learn More about Corinne Pankovcin's net worth.

How old is Corinne Pankovcin?

Ms. Pankovcin is currently 58 years old. There are 3 older executives and no younger executives at Aditxt. The oldest executive at Aditxt is Dr. Shahrokh Shabahang D.D.S., M.S., Ph.D., Co-Founder, Chief Innovation Officer, Secretary & Director, who is 61 years old. Learn More on Corinne Pankovcin's age.

What is Corinne Pankovcin's salary?

As the CFO of Aditxt, Inc., Ms. Pankovcin earns $366,770.00 per year. The highest earning executive at Aditxt is Mr. Amro A. Albanna, Co-Founder, Chairman & CEO, who commands a salary of $472,120.00 per year. Learn More on Corinne Pankovcin's salary.

How do I contact Corinne Pankovcin?

The corporate mailing address for Ms. Pankovcin and other Aditxt executives is 2569 WYANDOTTE ST. SUITE 101, MOUNTAIN CA, 94043. Aditxt can also be reached via phone at 650-870-1200 and via email at [email protected]. Learn More on Corinne Pankovcin's contact information.

Has Corinne Pankovcin been buying or selling shares of Aditxt?

Corinne Pankovcin has not been actively trading shares of Aditxt during the past quarter. Most recently, on Tuesday, May 25th, Corinne Pankovcin bought 2 shares of Aditxt stock. The stock was acquired at an average cost of $4,096.00 per share, with a total value of $8,192.00. Following the completion of the transaction, the chief financial officer now directly owns 71 shares of the company's stock, valued at $290,816. Learn More on Corinne Pankovcin's trading history.

Who are Aditxt's active insiders?

Aditxt's insider roster includes Thomas Farley (Insider), Corinne Pankovcin (CFO), and Shahrokh Shabahang (Insider). Learn More on Aditxt's active insiders.

Are insiders buying or selling shares of Aditxt?

During the last twelve months, insiders at the sold shares 1 times. They sold a total of 25,534 shares worth more than $29,874.78. The most recent insider tranaction occured on October, 16th when major shareholder Financial Lp Hrt sold 25,534 shares worth more than $29,874.78. Insiders at Aditxt own 1.7% of the company. Learn More about insider trades at Aditxt.

Information on this page was last updated on 10/16/2024.

Corinne Pankovcin Insider Trading History at Aditxt

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/25/2021Buy2$4,096.00$8,192.0071View SEC Filing Icon  
See Full Table

Corinne Pankovcin Buying and Selling Activity at Aditxt

This chart shows Corinne Pankovcin's buying and selling at Aditxt by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aditxt Company Overview

Aditxt logo
Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.
Read More

Today's Range

Now: $0.19
Low: $0.19
High: $0.21

50 Day Range

MA: $0.50
Low: $0.19
High: $1.12

2 Week Range

Now: $0.19
Low: $0.19
High: $338.80

Volume

10,700,260 shs

Average Volume

833,569 shs

Market Capitalization

$2.65 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.16
Missed Nvidia? Buy Elon Musk’s “Silent Partner”
From Brownstone Research   |   Ad
In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.
So please click here to see the details because a lot of people could get rich.